International Isotopes Inc
Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Devices, and Fluorine Products. The Ther… Read more
International Isotopes Inc (INIS) - Total Assets
Latest total assets as of September 2025: $17.85 Million USD
Based on the latest financial reports, International Isotopes Inc (INIS) holds total assets worth $17.85 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
International Isotopes Inc - Total Assets Trend (2000–2024)
This chart illustrates how International Isotopes Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
International Isotopes Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
International Isotopes Inc's total assets of $17.85 Million consist of 29.1% current assets and 71.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.3% |
| Accounts Receivable | $1.52 Million | 8.9% |
| Inventory | $820.89K | 4.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.37 Million | 19.7% |
| Goodwill | $1.38 Million | 8.1% |
Asset Composition Trend (2000–2024)
This chart illustrates how International Isotopes Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: International Isotopes Inc's current assets represent 29.1% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2024, up from 2.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 19.7% of total assets.
International Isotopes Inc Competitors by Total Assets
Key competitors of International Isotopes Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
International Isotopes Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - International Isotopes Inc generates 0.81x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, International Isotopes Inc generates $ 0.05 in net profit.
International Isotopes Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.35 | 1.58 | 0.71 |
| Quick Ratio | 1.06 | 1.32 | 0.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.29 Million | $ 1.91 Million | $ -1.67 Million |
International Isotopes Inc - Advanced Valuation Insights
This section examines the relationship between International Isotopes Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.96 |
| Latest Market Cap to Assets Ratio | 0.91 |
| Asset Growth Rate (YoY) | 1.5% |
| Total Assets | $17.16 Million |
| Market Capitalization | $15.69 Million USD |
Valuation Analysis
Near Book Valuation: The market values International Isotopes Inc's assets close to their book value ( 0.91x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: International Isotopes Inc's assets grew by 1.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for International Isotopes Inc (2000–2024)
The table below shows the annual total assets of International Isotopes Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $17.16 Million | +1.51% |
| 2023-12-31 | $16.91 Million | +4.07% |
| 2022-12-31 | $16.24 Million | -0.51% |
| 2021-12-31 | $16.33 Million | -4.50% |
| 2020-12-31 | $17.10 Million | +12.06% |
| 2019-12-31 | $15.26 Million | +17.45% |
| 2018-12-31 | $12.99 Million | +8.20% |
| 2017-12-31 | $12.01 Million | +5.50% |
| 2016-12-31 | $11.38 Million | +1.21% |
| 2015-12-31 | $11.24 Million | +2.68% |
| 2014-12-31 | $10.95 Million | -8.81% |
| 2013-12-31 | $12.01 Million | -0.28% |
| 2012-12-31 | $12.04 Million | +0.93% |
| 2011-12-31 | $11.93 Million | +6.26% |
| 2010-12-31 | $11.23 Million | +52.12% |
| 2009-12-31 | $7.38 Million | -25.74% |
| 2008-12-31 | $9.94 Million | +65.03% |
| 2007-12-31 | $6.02 Million | +7.50% |
| 2006-12-31 | $5.60 Million | -0.39% |
| 2005-12-31 | $5.62 Million | +28.19% |
| 2004-12-31 | $4.39 Million | +17.96% |
| 2003-12-31 | $3.72 Million | -4.93% |
| 2002-12-31 | $3.91 Million | -8.30% |
| 2001-12-31 | $4.27 Million | -85.58% |
| 2000-12-31 | $29.59 Million | -- |